Jun‐Sing Wang
Impact in
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes Treatment and Management 20
- Diabetes, Cardiovascular Risks, and Lipoproteins 16
- Diabetes Management and Research 15
- Nephrology 11
- Chronic Kidney Disease and Diabetes 9
- Co-authors
- Wayne Huey‐Herng Sheu (54 shared papers)I‐Te Lee (45 shared papers)Shih‐Yi Lin (29 shared papers)Wen‐Jane Lee (35 shared papers)Kae‐Woei Liang (28 shared papers)Chia‐Po Fu (16 shared papers)Wen-Lieng Lee (24 shared papers)Shih‐Li Su (7 shared papers)
- Journals
- Clinica Chimica Acta (8 papers)Scientific Reports (6 papers)Journal of Clinical Medicine (6 papers)Medicine (5 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (4 papers)
- Partner nations
- TaiwanUnited StatesPhilippines
In The Last Decade
Jun‐Sing Wang
98 papers receiving 4.6k citations
Jun‐Sing Wang's Hit Papers
Peers
Comparison fields: 5 of 104
- Endocrinology, Diabetes and Metabolism 2.5k
- Nephrology 491
- Genetics 621
- Cardiology and Cardiovascular Medicine 413
- Ophthalmology 125
Countries citing papers authored by Jun‐Sing Wang
This map shows the geographic impact of Jun‐Sing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun‐Sing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun‐Sing Wang more than expected).
Fields of papers citing papers by Jun‐Sing Wang
This network shows the impact of papers produced by Jun‐Sing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun‐Sing Wang. The network helps show where Jun‐Sing Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun‐Sing Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2019 | 2345 |
| 2 | The power of genetic diversity in genome-wide association studies of lipids Hit paper breakdown → | 2021 | 601 |
| 3 | Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 498 |
| 4 | 2015 | 104 | |
| 5 | 2010 | 95 | |
| 6 | 2019 | 94 | |
| 7 | 2013 | 84 | |
| 8 | 2017 | 72 | |
| 9 | 2011 | 61 | |
| 10 | 2022 | 47 | |
| 11 | 2017 | 43 | |
| 12 | 2011 | 32 | |
| 13 | 2013 | 31 | |
| 14 | 2018 | 31 | |
| 15 | 2015 | 29 | |
| 16 | 2016 | 28 | |
| 17 | 2022 | 28 | |
| 18 | 2013 | 26 | |
| 19 | 2022 | 23 | |
| 20 | 2021 | 22 |
About Jun‐Sing Wang
Jun‐Sing Wang is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Epidemiology, Surgery and Genetics, having authored 108 papers that have together received 4.8k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (20 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers), Diabetes Management and Research (15 papers), Genetic Associations and Epidemiology (10 papers), Chronic Kidney Disease and Diabetes (9 papers), Adipokines, Inflammation, and Metabolic Diseases (7 papers), Lipoproteins and Cardiovascular Health (5 papers) and Nutritional Studies and Diet (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.5k citations), Nephrology (491 citations), Genetics (621 citations), Cardiology and Cardiovascular Medicine (413 citations) and Ophthalmology (125 citations). Jun‐Sing Wang has collaborated with scholars based in Taiwan, United States and Philippines. Frequent co-authors include Wayne Huey‐Herng Sheu, I‐Te Lee, Shih‐Yi Lin, Wen‐Jane Lee, Kae‐Woei Liang, Chia‐Po Fu, Wen-Lieng Lee, Shih‐Li Su, Shih‐Te Tu and Shi-Dou Lin. Their work appears in journals such as Clinica Chimica Acta, Scientific Reports, Journal of Clinical Medicine, Medicine and Clinical Chemistry and Laboratory Medicine (CCLM).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.